Skip to main content
Top
Published in: Clinical Rheumatology 12/2021

01-12-2021 | Osteoporosis | Brief Report

Trends in hospitalizations for vertebral compression fracture in ankylosing spondylitis: data from the National Inpatient Sample 2000–2014

Authors: Rashmi Dhital, Ibiyemi Oke, Anthony Donato, Anish Paudel, Dilli Ram Poudel, Prakash Paudel, Paras Karmacharya

Published in: Clinical Rheumatology | Issue 12/2021

Login to get access

Abstract

Ankylosing spondylitis (AS) patients are at increased risk of vertebral compression fractures (VCF). Our objective was to examine the yearly trend of VCF hospitalizations in AS patients as compared to rheumatoid arthritis (RA) and the general population. National Inpatient Sample (NIS) database (2000–2014) was used to identify adult (≥ 18 years) hospitalizations, based on validated ICD-9 diagnosis codes. The rate of VCF hospitalizations, as a primary diagnosis, was assessed in three mutually exclusive groups: AS, RA, and the general population. The prevalence of VCF hospitalization was highest in AS (2.70%), compared to 0.77% in RA and 0.35% in the general population. Over the 15-year period, VCF hospitalization in AS was noted to have an increasing trend (Annual Percent Change (APC) = 4.73, p < 0.05) in contrast to the stable trend in the general population (APC = 0.34, p = NS) and a declining trend in RA (APC -3.61, p < 0.05). VCF related to AS was also associated with a longer hospital stay as compared to the general population (8.1 days vs. 5.1 days, p < 0.05) and higher inpatient mortality (3.4% vs. 1.0%, p < 0.05). A higher rate of VCF hospitalization along with an increasing trend was noted in AS as compared to RA and compared to the general population. Better screening approaches and treatment strategies for AS patients with VCF risk are urgently needed to reduce hospitalizations and related complications.
Key Points
An increasing trend of VCF hospitalization was noted in AS, in contrast to a declining trend in RA and a stable trend in the general population.
VCF in AS was associated with longer hospital stay and higher inpatient mortality than in RA and the general population.
Literature
18.
go back to reference Vosse D, Feldtkeller E, Erlendsson J et al (2004) Clinical vertebral fractures in patients with ankylosing spondylitis. J Rheumatol 31:1981–1985PubMed Vosse D, Feldtkeller E, Erlendsson J et al (2004) Clinical vertebral fractures in patients with ankylosing spondylitis. J Rheumatol 31:1981–1985PubMed
20.
go back to reference Robinson Y (2017) Spinal fractures related to ankylosing spondylitis : epidemiology, clinical outcome and biomechanics Robinson Y (2017) Spinal fractures related to ankylosing spondylitis : epidemiology, clinical outcome and biomechanics
22.
go back to reference Beek KJ, Rusman T, van der Weijden MAC et al (2019) Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis. J Bone Miner Res Off J Am Soc Bone Miner Res 34:1041–1048. https://doi.org/10.1002/jbmr.3684CrossRef Beek KJ, Rusman T, van der Weijden MAC et al (2019) Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis. J Bone Miner Res Off J Am Soc Bone Miner Res 34:1041–1048. https://​doi.​org/​10.​1002/​jbmr.​3684CrossRef
25.
go back to reference Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features? - Gavin Clunie, Nicole Horwood, 2020. https://journals.sagepub.com/doi/full/https://doi.org/10.1177/1759720X20969260. Accessed 8 Mar 2021 Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features? - Gavin Clunie, Nicole Horwood, 2020. https://​journals.​sagepub.​com/​doi/​full/​https://​doi.​org/​10.​1177/​1759720X20969260​. Accessed 8 Mar 2021
Metadata
Title
Trends in hospitalizations for vertebral compression fracture in ankylosing spondylitis: data from the National Inpatient Sample 2000–2014
Authors
Rashmi Dhital
Ibiyemi Oke
Anthony Donato
Anish Paudel
Dilli Ram Poudel
Prakash Paudel
Paras Karmacharya
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 12/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05842-0

Other articles of this Issue 12/2021

Clinical Rheumatology 12/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine